Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer
Position
Chief Medical Officer
Company
Nanoscope Therapeutics
DallasBiotechnologyHealth CareMedicalTherapeuticsDescription
Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, announced today the appointment of Samuel Barone, M.D., an accomplished leader in the pharmaceutical space and former FDA official, as Chief Medical Officer.
Quick answer
Nanoscope Therapeutics Strengthens Clinical and Regulatory Expertise With Appointment of Samuel Barone, M.D., as Chief Medical Officer (September 21, 2023). Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Who is the new Chief Medical Officer at Nanoscope Therapeutics?
- Nanoscope Therapeutics named Samuel Barone Chief Medical Officer, announced September 21, 2023.
- What did Nanoscope Therapeutics announce on September 21, 2023?
- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, announced today the appointment of Samuel Barone, M.D., an accomplished leader in the pharmaceutical space and former FDA official, as Chief Medical Officer.
- What does Nanoscope Therapeutics do?
- Nanoscope Therapeutics is developing mutation-agnostic, sight-restoring optogenetic therapies for the millions of patients blinded by retinal degenerative diseases for which no treatment currently exists.
- Where is Nanoscope Therapeutics based?
- Nanoscope Therapeutics is based in Dallas, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Strata Oncology (September 26, 2023), Mati Therapeutics (September 26, 2023), Pliant Therapeutics (September 15, 2023) and Arcutis (September 27, 2023) also announced leadership changes within 45 days of Nanoscope Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization (September 26, 2023)
- MATI THERAPEUTICS ANNOUNCES PROMOTION OF CHRIS MULLER TO CHIEF OPERATING OFFICER (September 26, 2023)
- Pliant Therapeutics Appoints Minnie Kuo as Chief (September 15, 2023)
- Arcutis Appoints L. Todd Edwards as Chief Commercial (September 27, 2023)
- Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., as Chief Medical Officer - Benzinga (September 29, 2023)
- 4DMT Appoints Uneek Mehra as Chief Financial and Business (September 12, 2023)
Who to call at Nanoscope Therapeutics, and when
A new leader at Nanoscope Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nanoscope Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nanoscope Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nanoscope Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nanoscope Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nanoscope Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.